Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-100
SponsorMackay Medical College
About this trial
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.
Eligibility criteria
Qualifiers
Pelvic organ prolapse patients with objective / subjective voiding dysfunctions
Underwent surgery for symptomatic POP ≥ stage II (POP-Q system)
Disqualifiers
Patients with a history of pelvic radiation.
Patients with a history of vesico-/recto-/urethra-vaginal fistula
Patients unable to be followed up.
Trial design
Treatments tested in this trial
- Urodynamic investigations before and after a mesh surgery protocol.
- Urodynamic investigations before and after a robotic-assisted sacrocolpopexy protocol.
- Urodynamic investigations before and after a hysterectomy with trans-vaginal mesh repair
Treatment groups
150 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov